Sager Omer, Dincoglan Ferrat, Demiral Selcuk, Uysal Bora, Gamsiz Hakan, Colak Onurhan, Ozcan Fatih, Gundem Esin, Elcim Yelda, Dirican Bahar, Beyzadeoglu Murat
Department of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 06018, Turkey.
World J Methodol. 2021 May 20;11(3):61-74. doi: 10.5662/wjm.v11.i3.61.
Brain tumors, which are among the most common solid tumors in childhood, remain a leading cause of cancer-related mortality in pediatric population. Gliomas, which may be broadly categorized as low grade glioma and high grade glioma, account for the majority of brain tumors in children. Expectant management, surgery, radiation therapy (RT), chemotherapy, targeted therapy or combinations of these modalities may be used for management of pediatric gliomas. Several patient, tumor and treatment-related characteristics including age, lesion size, grade, location, phenotypic and genotypic features, symptomatology, predicted outcomes and toxicity profile of available therapeutic options should be considered in decision making for optimal treatment. Management of pediatric gliomas poses a formidable challenge to the physicians due to concerns about treatment induced toxicity. Adverse effects of therapy may include neurological deficits, hemiparesis, dysphagia, ataxia, spasticity, endocrine sequelae, neurocognitive and communication impairment, deterioration in quality of life, adverse socioeconomic consequences, and secondary cancers. Nevertheless, improved understanding of molecular pathology and technological advancements may pave the way for progress in management of pediatric glial neoplasms. Multidisciplinary management with close collaboration of disciplines including pediatric oncology, surgery, and radiation oncology is warranted to achieve optimal therapeutic outcomes. In the context of RT, stereotactic irradiation is a viable treatment modality for several central nervous system disorders and brain tumors. Considering the importance of minimizing adverse effects of irradiation, radiosurgery has attracted great attention for clinical applications in both adults and children. Radiosurgical applications offer great potential for improving the toxicity profile of radiation delivery by focused and precise targeting of well-defined tumors under stereotactic immobilization and image guidance. Herein, we provide a concise review of stereotactic irradiation for pediatric glial neoplasms in light of the literature.
脑肿瘤是儿童最常见的实体瘤之一,仍然是儿科人群中癌症相关死亡的主要原因。胶质瘤可大致分为低级别胶质瘤和高级别胶质瘤,占儿童脑肿瘤的大多数。观察性管理、手术、放射治疗(RT)、化疗、靶向治疗或这些方式的联合应用可用于小儿胶质瘤的治疗。在做出最佳治疗决策时,应考虑几个与患者、肿瘤和治疗相关的特征,包括年龄、病变大小、分级、位置、表型和基因型特征、症状、预测结果以及现有治疗方案的毒性特征。由于担心治疗引起的毒性,小儿胶质瘤的治疗给医生带来了巨大挑战。治疗的不良反应可能包括神经功能缺损、偏瘫、吞咽困难、共济失调、痉挛、内分泌后遗症、神经认知和沟通障碍、生活质量下降、不良的社会经济后果以及继发性癌症。然而,对分子病理学的深入了解和技术进步可能为小儿胶质肿瘤的治疗进展铺平道路。需要包括儿科肿瘤学、外科和放射肿瘤学在内的多学科密切合作进行多学科管理,以实现最佳治疗效果。在放射治疗方面,立体定向放射是治疗几种中枢神经系统疾病和脑肿瘤的可行治疗方式。考虑到尽量减少辐射不良反应的重要性,放射外科在成人和儿童的临床应用中都引起了极大关注。放射外科应用通过在立体定向固定和图像引导下对明确的肿瘤进行聚焦和精确靶向,在改善放射治疗的毒性特征方面具有巨大潜力。在此,我们根据文献对小儿胶质肿瘤的立体定向放射治疗进行简要综述。